Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Red Blood Cell as a Mediator and Therapeutic Target in Cardiovascular Disease

NCT07151222 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07151222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07151222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Red Blood Cell as a Mediator and Therapeutic Target in Cardiovascular Disease
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2017
Completion date
December 30, 2031
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus